Informations sur le produit
- Quinoline, 2-methyl-4-(1-piperazinyl)-
- 2-Methyl-4-Piperazinoquinoline
2-Methyl-4-piperazinoQuinoline is an inhibitor of the enzyme fatty acid synthase. It is a lipoprotein associated compound that has been shown to inhibit the growth of human breast cancer cells. The reaction product between 2-methyl-4-piperazinoQuinoline and a lipoprotein results in a structural modification that inhibits the activity of the enzyme fatty acid synthase, which is involved in lipid synthesis and cell proliferation. This drug is currently in clinical development for use in cancer therapy.